Formulation design and evaluation of quantum dot-loaded nanostructured lipid carriers for integrating bioimaging and anticancer therapy

Nanomedicine

Volumn 8, Issue 8, 2013, Pages 1253-1269

  Hsu, Shu Hui ^a,b   Wen, Chih Jen ^c,d   Al Suwayeh, Saleh A ^e   Huang, Yu Jie ^a   Fang, Jia You ^c,f  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b R and D Standard Chemical and Pharmaceutical Co Ltd   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d Chang Gung Medical Foundation LinKou Branch   (Taiwan)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

camptothecin; drug delivery; nanocarrier; nanostructured lipid carrier; quantum dot

Indexed keywords

CAMPTOTHECIN; CARBOXYLIC ACID; IRINOTECAN; NANOCARRIER; QUANTUM DOT; QUANTUM DOT NANOSTRUCTURED LIPID CARRIER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CELL MIGRATION; CELL SURVIVAL; CELL TRANSPORT; CELL VIABILITY; CONTROLLED STUDY; CRYSTALLIZATION; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ACCUMULATION; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG TUMOR LEVEL; EX VIVO STUDY; FEMALE; HYDROPHILICITY; IN VIVO STUDY; INTERNALIZATION; MELANOMA CELL; MOUSE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CELL LINE, TUMOR; CELL PROLIFERATION; DIAGNOSTIC IMAGING; DRUG CARRIERS; HUMANS; LIPIDS; NANOSTRUCTURES; NEOPLASMS; POLYETHYLENE GLYCOLS; QUANTUM DOTS;

EID: 84892141842     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.170     Document Type: Article

References (45)

1. Debbage P, Jaschke W. Molecular imaging with nanoparticles: Giant roles for dwarf actors. Histochem. Cell. Biol. 30, 845-875 (2008
2. Al-Jamal WT, Kostarelos K. Liposomes: From a clinically established drug-delivery system to a nanoparticle platform for theranostic nanomedicine. Acc. Chem. Res. 44, 1094-1104 (2011
3. Wang Y, Chen L. Quantum dots, lighting up the research and development of nanomedicine. Nanomed. Nanotechnol. Biol. Med. 7, 385-402 (2011
4. Wang C, Gao X, Su X. In vitro and in vivo imaging with quantum dots. Anal. Bioanal. Chem. 397, 1397-1415 (2010
5. Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: Drug delivery, image-guided therapy, and multifunctional platforms. Appl. Biochem. Biotechnol. 165, 1628-1651 (2011
6. Bothun GD, Rabideau AE, Stoner MA. Hepatoma cell uptake of cationic multifluorescent quantum dot liposomes. J. Phys. Chem. B 113, 7725-7728 (2009
7. Li Z, Huang P, Lin J et al. Arginine-glycine-Aspartic acid-conjugated dendrimer-modified quantum dots for targeting and imaging melanoma. J. Nanosci. Nanotechnol. 10, 4859-4867 (2010
8. Al-Jamal WT, Al-Jamal KT, Bomans PH, Frederik PM, Kostarelos K. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. Small 4, 1406-1415 (2008
9. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54, S131-S155 (2002
10. Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J. Colloid Interf. Sci. 334, 75-81 (2009
11. Lorence A, Nessler CL. Camptothecin, over four decades of surprising findings. Phytochemistry 6, 2735-2749 (2004
12. Zhang X, Pan W, Gan L, Zhu C, Gan Y, Nie S. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Chem. Pharm. Bull. 56, 1645-1650 (2008
13. Huang ZR, Hua SC, Yang YL, Fang JY. Development and evaluation of lipid nanoparticles for camptothecin delivery: A comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sin. 29, 1094-1102 (2008
14. Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM. Polyhydroxy surfactants for the formation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure. Int. J. Pharm. 406, 163-172 (2011
15. Mukthavaram R, Wrasidlo W, Hall D, Kesari S, Makale M. Assembly and targeting of liposomal nanoparticles encapsulating quantum dots. Bioconjugate Chem. 22, 1638-1644 (2011
16. Biju V, Mundayoor S, Omkumar RV, Anas A, Ishikawa M. Bioconjugated quantum dots for cancer research: Present status, prospects and remaining issues. Biotechnol. Adv. 28, 199-213 (2010
17. Ozkan M. Quantum dots and other nanoparticles: What can they offer to drug discovery? Drug Discover. Today 9, 1065-1071 (2004
18. Ryan SM, Mantovani G, Wang X, Haddleton DM, Brayden DJ. Advances in PEGylation of important biotech molecules delivery aspects. Expert Opin. Drug Deliv. 5, 371-383 (2008
19. Edmund AR, Kambalapally S, Wilson TA, Nicolosi RJ. Encapsulation of cadmium selenide quantum dots using a self-Assembling nanoemulsion (SANE) reduces their in vitro toxicity. Toxicol. In Vitro 25, 185-190 (2011
20. Bunjes H, Koch MHJ, Westesen K. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. J. Pharm. Sci. 92, 1509-1520 (2003
21. Wilde PJ, Chu BS. Interfacial and colloidal aspects of lipid digestion. Adv. Colloid Interf. Sci. 165, 14-22 (2011
22. Nagasaki Y, Ishii T, Sunaga Y, Watanabe Y, Otsuka H, Kataoka K. Novel molecular recognition via fluorescent resonance energy transfer using a biotin-PEG/polyamine stabilized CdS quantum dot. Langmuir 20, 6396-6400 (2004
23. Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Pharm. Res. 22, 1887-1897 (2005
24. Müller RH, Runge SA, Ravelli V, Thünemann AF, Mehnert W, Souto EB. Cyclosporine-loaded solid lipid nanoparticles (SLN®): Drug-lipid physicochemical interactions and characterization of drug incorporation. Eur. J. Pharm. Biopharm. 68, 535-544 (2008
25. Wang JJ, Liu KS, Sung KC, Tsai CY, Fang JY. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur. J. Pharm. Sci. 38, 138-146 (2009
26. Clausse D, Gomez F, Pezron I, Komunjer L, Dalmazzone C. Morphology characterization of emulsions by differential scanning calorimetry. Adv. Colloid Interf. Sci. 117, 59-74 (2005
27. Schubert MA, Harms M, Müller-Goymann CC. Structural investigations on lipid nanoparticles containing high amounts of lecithin. Eur. J. Pharm. Sci. 27, 226-236 (2006
28. Marsh S, Hoskins JM. Irinotecan pharmacogenomics. Pharmacogenomics 11, 1003-1010 (2010
29. Souza LG, Silva EJ, Martins ALL et al. Development of topotecan loaded lipid nanoarticles for chemical stabilization and prolonged release. Eur. J. Pharm. Biopharm. 79, 189-196 (2011
30. Kloepfer JA, Cohen N, Nadeau JL. FRET between CdSe quantum dots in lipid vesicles and water-And lipid-soluble dyes. J. Phys. Chem. B 108, 17042-17049 (2004
31. Hatefi A, Amsden B. Camptothecin delivery methods. Pharm. Res. 19, 1389-1399 (2002
32. Zanella F, Renner O, García B et al. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells. Oncogene 29, 2973-2982 (2010
33. MacKie RM, Hauschild A, Eggermont AMM. Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 20(Suppl. 6), vi1-vi7 (2009
34. Liu D, Liu F, Liu Z, Wang L, Zhang N. Tumor specific delivery and therapy by double-Targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol. Pharm. 8, 2291-2301 (2011
35. Liu D, Liu Z, Wang L, Zhang C, Zhang N. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf. B Interf. 85, 262-269 (2011
36. Yang S, Zhu J, Lu Y, Liang B, Yang C. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm. Res. 16, 751-757 (1999
37. Sinnberg T, Lasithiotakis K, Niessner H et al. Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide. J. Invest. Dermatol. 129, 1500-1515 (2009
38. Sun D, Yang K, Zheng G, Li Z, Cao Y. Study on effect of peptide-conjugated near-infrared fluorescent quantum dots on the clone formation, proliferation, apoptosis, and tumorigenicity ability of human buccal squamous cell carcinoma cell line BcaCD885. Int. J. Nanomed. 5, 401-405 (2010
39. Dudu V, Ramcharan M, Gilchrist ML, Holland EC, Vazquez M. Liposome delivery of quantum dots to the cytosol of live cells. J. Nanosci. Nanotechnol. 8, 2293-2300 (2008
40. Wen CJ, Zhang LW, Al-Suwayeh SA, Yen TC, Fang JY. Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging. Int. J. Nanomed. 7, 1599-1611 (2012
41. Selim KMK, Xing ZC, Choi MJ, Chang Y, Guo H, Kang IK. Reduced cytotoxicity of insulin-immobilized CdS quantum dots using PEG as a spacer. Nanoscale Res. Lett. 6, 528 (2011
42. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: Relevance to drug delivery. Cell. Mol. Life Sci. 66, 2873-2896 (2009
43. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labeling and sensing. Nat. Mat. 4, 435-446 (2005
44. Generalov R, Kavaliauskiene S, Westrøm S, Chen W, Kristensen S, Juzenas P. Entrapment in phospholipid vesicles quenches photoactivity of quantum dots. Int. J. Nanomed. 6, 1875-1888 (2011
45. Pan J, Feng SS. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials 30, 1176-1183 (2009